Octreotide: Entering the New Era of Peptidomimetic Therapy

Longnecker SM . Somatostatin and octreotide: literature review and description of therapeutic activity in pancreatic neoplasia. Drug Intell Clin Pharm 1988; 22: 99106.

Longnecker SM . Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide. Drug Intell Clin Pharm 1988; 22: 1368.

Katz MD , Erstad BL , Rose C . Treatment of severe cryptosporidium-related diarrhea with octreotide in a patient with AIDS. Drug Intell Clin Pharm 1988; 22: 1346.

O'DORISIO TM , Gaginella TS , Mekhjian HS , O'DORISIO MS . Somatostatin and analogs in the treatment of VIPoma. Ann NY Acad Sci (in press).

Santangelo WC , O'DORISIO TM , Kim JG , Severino G , Krejs G . VIPoma syndrome: effect of a synthetic somatostatin analogue. Scand J Gastroenterol 1986; 21: 18790.

Richter G , Stockmann F , Lembcke B , Conlon JM , Creutz Feldt W . Short-term administration of the somatostatin analogue SMS 201-995 in patients with carcinoid tumors. Scand J Gastroenterol 1986; 21: 1938.

Oseik , O'DORISIO TM . Malignant insulinoma: effects of a somatostatin analog (compound 201-995) on serum glucose, growth and gastro-entero-pancreatic hormones. Ann Intern Med 1985; 103: 2235.

Ruff MR , Martin BM , Guins EL , Farrar WL , Pert CB . CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxis. Relationship to vasoactive intestinal polypeptide. FEBS Lett 1987; 211: 1722.

Gaginella TS , Hubel KA , O'DORISIO TM . Vasoactive intestinal polypeptide and intestinal chloride secretion. In: Said I ed. Vasoactive intestinal peptide. New York: Raven Press, 1982: 21122. (Advances in peptide hormone research series; vol 1.)